Using artificial intelligence to improve understanding and treatment of Alzheimer's disease

Artificial Intelligence Strategies for Alzheimer's Disease Research

NIH-funded research Cedars-Sinai Medical Center · NIH-10902053

This study is using smart computer technology to look at a lot of information about Alzheimer's disease to find new clues about what causes it, making it easier for researchers to understand and help those affected.

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionCedars-Sinai Medical Center NIH-funded
Lab location1 site (Los Angeles, United States)
Project IDNIH-10902053 on NIH RePORTER

What this research studies

This research focuses on leveraging artificial intelligence (AI) and machine learning to analyze large-scale data related to Alzheimer's disease (AD). By developing advanced algorithms, the project aims to uncover hidden patterns in clinical and biological data that traditional methods may overlook. The PennAI method will automate the selection of machine learning techniques, making it easier for researchers to analyze complex data. This innovative approach could lead to better insights into the genetic and biological factors contributing to AD.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals diagnosed with Alzheimer's disease or those at risk of developing it.

Not a fit: Patients with other forms of dementia unrelated to Alzheimer's may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved diagnostic tools and treatment strategies for Alzheimer's disease.

How similar studies have performed: Previous research has shown promise in using AI for analyzing complex health data, indicating a strong potential for success in this novel approach.

Where this research is happening

Los Angeles, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's DiseaseAlzheimer's disease biological marker
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.